OVID / Ovid Therapeutics Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Ovid Therapeutics Inc.
US ˙ NasdaqCM ˙ US6904691010

Deler fremragende 173,037,131 shares
Insideraktier25.594.439 shares
Insider ejerskab14,79 %
Total Insiders20
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

-2 ( )
9956 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

-0.014% ( )
9618 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Ovid Therapeutics Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Alexander Margaret A. President and CEO, Director - [D] [O] 61.750 61.750
Karen Bernstein Director - [D] 20.000 20.000
Timothy Daly 125.000
Barbara Gayle Duncan 21.347
Matthew During President and CSO, Director, 10% Owner - [D] [O] [10%] 4.307.314 4.307.314
Kevin Joseph Fitzgerald Director - [D] 17.578 17.578
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Bart Friedman Director - [D] 8.789 8.789
Dirk Haasner 100.000
Jeremy M Levin Executive Chairman, Director - [D] [O] 3.735.048 3.735.048
Millennium Pharmaceuticals Inc 10% Owner - [10%] 5.750.000 9.281.996
Stelios Papadopoulos Director - [D] 217.578 217.578
Thomas Michael Perone General Counsel, Secretary - [O] 28.125 28.125
Robert Michael Poole 15.000
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Amit Rakhit President and CMO - [O] 726.823 726.823
Jeffrey A Rona CBFO - [O] 156.313 156.313
Pharmaceutical Co Ltd Takeda 10% Owner - [10%] 7.000.000 7.000.000
Jason Tardio Chief Operating Officer - [O] 28.125 28.125
Douglas E Williams Director - [D] 5.000 5.000
Ana Ward 40.000
Yaron Werber 131.000

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i OVID / Ovid Therapeutics Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2025-01-27 ALEXANDER MARGARET A. 6.810 0,7300 6.810 0,7300 4.971 249 1.8400 7.559 152,07
2024-03-18 LEVIN JEREMY M 18.248 2,7600 18.248 2,7600 50.364
2020-08-28 LEVIN JEREMY M 8.488 5,8400 8.488 5,8400 49.570
2019-10-08 TAKEDA PHARMACEUTICAL CO LTD 2.000.000 2,5000 2.000.000 2,5000 5.000.000
2019-10-08 LEVIN JEREMY M 60.000 2,5000 60.000 2,5000 150.000
2019-02-26 Bernstein Karen 10.000 2,0210 10.000 2,0210 20.210
2019-02-22 LEVIN JEREMY M 75.000 2,0000 75.000 2,0000 150.000
2018-08-14 WILLIAMS DOUGLAS E 5.000 6,4883 5.000 6,4883 32.442
2018-08-14 Bernstein Karen 10.000 6,2300 10.000 6,2300 62.300
2017-08-25 LEVIN JEREMY M 15.334 7,1500 15.334 7,1500 109.638

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

OVID / Ovid Therapeutics Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i OVID / Ovid Therapeutics Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-02-23 ALEXANDER MARGARET A. 11.656 1,4500 11.656 1,4500 16.901 0 1.4500 0 0,00
2026-02-23 Rona Jeffrey A 8.541 1,4500 8.541 1,4500 12.384
2025-02-26 ALEXANDER MARGARET A. 5.279 0,5600 5.279 0,5600 2.956
2025-02-26 Rona Jeffrey A 3.902 0,5600 3.902 0,5600 2.185
2022-09-12 Tardio Jason 17.344 2,1500 17.344 2,1500 37.290
2021-07-14 Rakhit Amit 34.017 3,7100 34.017 3,7100 126.203

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

OVID / Ovid Therapeutics Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-04-09 2026-04-07 4 Friedman Bart OVID Common Stock A - Award D 2,5600 8.789 22 8.789
2026-04-09 2026-04-07 4 PAPADOPOULOS STELIOS OVID Common Stock A - Award D 2,5600 17.578 45 217.578
2026-04-09 2026-04-07 4 Fitzgerald Kevin Joseph OVID Common Stock A - Award D 2,5600 17.578 45 17.578
2026-03-25 2026-03-23 4 LEVIN JEREMY M OVID Common Stock M - Exercise D 1,4000 47.333 66 3.735.048
2026-03-02 2026-02-23 4 ALEXANDER MARGARET A. OVID Common Stock S - Sale D 1,4500 -11.656 -17 61.750
2026-03-02 2026-02-26 4 Rona Jeffrey A OVID Common Stock A - Award D 68.125 156.313
2026-03-02 2026-02-23 4 Rona Jeffrey A OVID Common Stock S - Sale D 1,4500 -8.541 -12 88.188
2025-12-18 2025-12-15 4 LEVIN JEREMY M OVID Common Stock C - Conversion D 71.000 3.687.715
2025-12-09 2025-12-08 4 TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses OVID Common Stock C - Conversion I 1.250.000 7.000.000
2025-03-04 3 PAPADOPOULOS STELIOS OVID Common Stock D 200.000
2025-02-28 2025-02-26 4 Rona Jeffrey A OVID Common Stock S - Sale D 0,5600 -3.902 -2 67.973
2025-02-28 2025-02-26 4 ALEXANDER MARGARET A. OVID Common Stock S - Sale D 0,5600 -5.279 -3 73.406
2025-02-24 2025-02-20 4 Rona Jeffrey A OVID Common Stock A - Award D 43.750 71.875
2025-02-24 2025-02-20 4 ALEXANDER MARGARET A. OVID Common Stock A - Award D 43.750 78.685
2025-01-29 2025-01-27 4 ALEXANDER MARGARET A. OVID Common Stock P - Purchase D 0,7300 6.810 5 34.935
2024-09-11 3 ALEXANDER MARGARET A. OVID Common Stock D 28.125
2024-03-20 2024-03-18 4 LEVIN JEREMY M OVID Common Stock P - Purchase D 2,7600 18.248 50 3.616.715
2024-02-26 2024-02-22 4 Tardio Jason OVID Common Stock A - Award D 28.125 28.125
2024-02-26 2024-02-22 4 Rona Jeffrey A OVID Common Stock A - Award D 28.125 28.125
2024-02-26 2024-02-22 4 Perone Thomas Michael OVID Common Stock A - Award D 28.125 28.125
2024-02-14 2019-09-20 4/A LEVIN JEREMY M OVID Common Stock G - Gift I -465.116 0
2023-12-06 2023-12-04 4 LEVIN JEREMY M OVID Common Stock G - Gift D -573.275 3.598.467
2023-12-06 2023-12-04 4 LEVIN JEREMY M OVID Common Stock G - Gift D -573.275 3.598.467
2022-09-14 2022-09-12 4 Tardio Jason OVID Common Stock S - Sale D 2,1500 -17.344 -37 0
2022-07-06 2022-07-01 4 TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses OVID Common Stock J - Other I 5.750.000 5.750.000
2022-07-06 2022-07-01 4 TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses OVID Common Stock J - Other I -5.750.000 0
2022-04-12 2022-04-08 4 Friedman Bart OVID Stock Option (Right to Buy) A - Award D 3,22 69.424 69.424
2022-04-12 2022-04-08 4 Tardio Jason OVID Stock Option (Right to Buy) A - Award D 3,22 10.000 10.000
2022-04-12 2022-04-08 4 Tardio Jason OVID Stock Option (Right to Buy) A - Award D 3,22 87.498 87.498
2022-04-12 2022-04-08 4 LEVIN JEREMY M OVID Stock Option (Right to Buy) A - Award D 3,22 423.244 423.244
2022-04-12 2022-04-08 4 Rona Jeffrey A OVID Stock Option (Right to Buy) A - Award D 3,22 10.000 10.000
2022-04-12 2022-04-08 4 Rona Jeffrey A OVID Stock Option (Right to Buy) A - Award D 3,22 194.399 194.399
2022-04-12 2022-04-08 4 Perone Thomas Michael OVID Stock Option (Right to Buy) A - Award D 3,22 10.000 10.000
2022-04-12 2022-04-08 4 Perone Thomas Michael OVID Stock Option (Right to Buy) A - Award D 3,22 25.399 25.399
2022-04-12 2022-04-08 4 Duncan Barbara Gayle OVID Stock Option (Right to Buy) A - Award D 3,22 21.347 21.347
2022-04-12 2022-04-08 4 Bernstein Karen OVID Stock Option (right to buy) A - Award D 3,22 69.424 69.424
2022-02-04 2022-02-03 4 Poole Robert Michael OVID Stock Option (Right to Buy) A - Award D 2,72 15.000 15.000
2022-02-04 2022-02-03 4 Friedman Bart OVID Stock Option (Right to Buy) A - Award D 2,72 15.000 15.000
2022-02-04 2022-02-03 4 Duncan Barbara Gayle OVID Stock Option (Right to Buy) A - Award D 2,72 15.000 15.000
2022-02-04 2022-02-03 4 Fitzgerald Kevin Joseph OVID Stock Option (Right to Buy) A - Award D 2,72 15.000 15.000
2022-02-04 2022-02-03 4 Bernstein Karen OVID Stock Option (Right to Buy) A - Award D 2,72 15.000 15.000
2022-02-04 2022-02-03 4 Tardio Jason OVID Stock Option (Right to Buy) A - Award D 2,72 175.000 175.000
2022-02-04 2022-02-03 4 Rona Jeffrey A OVID Stock Option (Right to Buy) A - Award D 2,72 218.750 218.750
2022-02-04 2022-02-03 4 Perone Thomas Michael OVID Stock Option (Right to Buy) A - Award D 2,72 175.000 175.000
2022-02-04 2022-02-03 4 LEVIN JEREMY M OVID Stock Option (Right to Buy) A - Award D 2,72 600.000 600.000
2021-10-07 2021-10-06 4 Fitzgerald Kevin Joseph OVID Stock Option (Right to Buy) A - Award D 3,44 30.000 30.000
2021-07-16 2021-07-14 4 Rakhit Amit OVID Stock Option (Right to Buy) M - Exercise D 1,89 34.017 90.983
2021-07-16 2021-07-14 4 Rakhit Amit OVID Common Stock S - Sale D 3,7100 -34.017 -126 726.823
2021-07-16 2021-07-14 4 Rakhit Amit OVID Common Stock M - Exercise D 1,8900 34.017 64 760.840
2021-07-13 2021-07-09 4 Poole Robert Michael OVID Stock Option (Right to Buy) A - Award D 3,94 30.000 30.000
2021-07-01 2021-07-01 4 Tardio Jason OVID Stock Option (Right to Buy) A - Award D 3,95 50.000 50.000
2021-06-11 2021-06-11 4 Duncan Barbara Gayle OVID Stock Option (Right to Buy) A - Award D 4,49 15.000 15.000
2021-06-11 2021-06-11 4 Friedman Bart OVID Stock Option (Right to Buy) A - Award D 4,49 15.000 15.000
2021-06-11 2021-06-11 4 Bernstein Karen OVID Stock Option (Right to Buy) A - Award D 4,49 15.000 15.000
2021-06-10 2021-06-02 4 Rona Jeffrey A OVID Stock Option (Right to Buy) A - Award D 4,42 100.000 100.000
2021-05-18 2021-05-17 4 WILLIAMS DOUGLAS E OVID Stock Option (Right to Buy) A - Award D 3,67 1.750 1.750
2021-05-18 2021-05-17 4 Friedman Bart OVID Stock Option (Right to Buy) A - Award D 3,67 1.750 1.750
2021-05-18 2021-05-17 4 Duncan Barbara Gayle OVID Stock Option (Right to Buy) A - Award D 3,67 1.750 1.750
2021-05-18 2021-05-17 4 Bernstein Karen OVID Stock Option (Right to Buy) A - Award D 3,67 1.750 1.750
2021-04-29 2020-11-25 4 Perone Thomas Michael OVID Stock Option (Right to Buy) A - Award D 3,66 44.000 44.000
2021-04-29 2020-11-25 4 Tardio Jason OVID Stock Option (Right to Buy) A - Award D 3,66 44.000 44.000
2021-02-08 2021-02-05 4 Tardio Jason OVID Stock Option (Right to Buy) A - Award D 7,40 75.000 75.000
2020-12-21 2020-12-17 4 Tardio Jason OVID Stock Option (Right to Buy) A - Award D 2,82 175.000 175.000
2020-12-21 2020-12-17 4 Perone Thomas Michael OVID Stock Option (Right to Buy) A - Award D 2,82 175.000 175.000
2020-12-21 2020-12-17 4 Rona Jeffrey A OVID Stock Option (Right to Buy) A - Award D 2,82 175.000 175.000
2020-12-21 2020-12-17 4 Rakhit Amit OVID Stock Option (Right to Buy) A - Award D 2,82 200.000 200.000
2020-12-21 2020-12-17 4 LEVIN JEREMY M OVID Stock Option (Right to Buy) A - Award D 2,82 650.000 650.000
2020-12-21 2020-12-17 4 Haasner Dirk OVID Stock Option (Right to Buy) A - Award D 2,82 100.000 100.000
2020-12-21 2020-12-17 4 Daly Timothy OVID Stock Option (Right to Buy) A - Award D 2,82 125.000 125.000
2020-10-13 2020-10-11 4 Rona Jeffrey A OVID Stock Option (Right to Buy) A - Award D 5,65 20.000 20.000
2020-10-13 2020-10-11 4 Haasner Dirk OVID Stock option (Right to Buy) A - Award D 5,65 20.000 20.000
2020-10-13 2020-10-11 4 Perone Thomas Michael OVID Stock Option (Right to Buy) A - Award D 5,65 20.000 20.000
2020-10-02 2020-09-30 4 Rona Jeffrey A OVID Stock Option (Right to Buy) A - Award D 5,74 325.000 325.000
2020-09-01 2020-08-28 4 LEVIN JEREMY M OVID Common Stock P - Purchase D 5,8400 8.488 50 5.792.530
2020-06-23 2020-06-19 4 Tardio Jason OVID Stock Option (Right to Buy) A - Award D 7,40 50.000 50.000
2020-06-08 2020-06-05 4 Bernstein Karen OVID Stock Option (Right to Buy) A - Award D 5,29 13.250 13.250
2020-06-08 2020-06-05 4 Duncan Barbara Gayle OVID Stock Option (Right to Buy) A - Award D 5,29 13.250 13.250
2020-06-08 2020-06-05 4 Friedman Bart OVID Stock Option (Right to Buy) A - Award D 5,29 13.250 13.250
2020-06-08 2020-06-05 4 WILLIAMS DOUGLAS E OVID Stock Option (Right to Buy) A - Award D 5,29 13.250 13.250
2020-01-02 2020-01-01 4 Perone Thomas Michael OVID Stock Option (Right to Buy) A - Award D 4,15 75.000 75.000
2019-12-20 2019-12-18 4 Perone Thomas Michael OVID Stock Option (Right to Buy) A - Award D 4,42 100.000 100.000
2019-12-20 2019-12-18 4 Daly Timothy OVID Stock Option (Right to Buy) A - Award D 4,42 125.000 125.000
2019-12-20 2019-12-18 4 Haasner Dirk OVID Stock Option (Right to Buy) A - Award D 4,42 100.000 100.000
2019-12-20 2019-12-18 4 LEVIN JEREMY M OVID Stock Option (Right to Buy) A - Award D 4,42 600.000 600.000
2019-12-20 2019-12-18 4 Rakhit Amit OVID Stock Option (Right to Buy) A - Award D 4,42 200.000 200.000
2019-11-22 3 MILLENNIUM PHARMACEUTICALS INC See Explanation of Responses OVID Common Stock I 9.281.996
2019-11-22 3 MILLENNIUM PHARMACEUTICALS INC See Explanation of Responses OVID Common Stock I 9.281.996
2019-11-22 3 MILLENNIUM PHARMACEUTICALS INC OVID Common Stock D 7.313.992
2019-11-22 3 MILLENNIUM PHARMACEUTICALS INC See Explanation of Responses OVID Common Stock I 9.281.996
2019-11-22 3 MILLENNIUM PHARMACEUTICALS INC OVID Common Stock D 7.313.992
2019-11-22 3 MILLENNIUM PHARMACEUTICALS INC See Explanation of Responses OVID Common Stock I 9.281.996
2019-11-22 3 MILLENNIUM PHARMACEUTICALS INC OVID Common Stock D 7.313.992
2019-11-22 3 MILLENNIUM PHARMACEUTICALS INC OVID Common Stock D 7.313.992
2019-11-22 2019-10-08 4 TAKEDA PHARMACEUTICAL CO LTD See Explanation of Responses OVID Common Stock P - Purchase I 2,5000 2.000.000 5.000 5.750.000
2019-11-21 2019-11-18 4 Tardio Jason OVID Stock Option (Right to Buy) A - Award D 2,76 125.000 125.000
2019-11-15 2019-11-13 4 Bernstein Karen OVID Stock Option (right to buy) A - Award D 2,43 7.437 7.437
2019-11-15 2019-11-13 4 Duncan Barbara Gayle OVID Stock Option (right to buy) A - Award D 2,43 7.437 7.437
2019-11-15 2019-11-13 4 Friedman Bart OVID Stock Option (right to buy) A - Award D 2,43 7.437 7.437
2019-11-15 2019-11-13 4 WILLIAMS DOUGLAS E OVID Stock Option (right to buy) A - Award D 2,43 7.437 7.437
2019-11-04 2019-11-01 4 Daly Timothy OVID Employee stock option (right to buy) A - Award D 2,46 25.000 25.000
2019-11-04 2019-11-01 4 Rakhit Amit OVID Common Stock (right to buy) A - Award D 2,46 75.000 75.000
2019-10-10 2019-10-08 4 LEVIN JEREMY M OVID Common Stock P - Purchase D 2,5000 60.000 150 4.736.529
2019-08-02 2019-06-10 4 Friedman Bart OVID Stock Option (Right to Buy) A - Award D 1,65 5.813 5.813
2019-08-01 2019-06-10 4/A Bernstein Karen OVID Stock Option (Right to Buy) A - Award D 1,65 5.813 5.813
2019-08-01 2019-06-10 4/A Duncan Barbara Gayle OVID Stock Option (Right to Buy) A - Award D 1,65 5.813 5.813
2019-08-01 2019-06-10 4/A WILLIAMS DOUGLAS E OVID Stock Option (Right to Buy) A - Award D 1,65 5.813 5.813
2019-06-10 2019-06-07 4 Bernstein Karen OVID Stock Option (Right to Buy) A - Award D 1,60 5.813 5.813
2019-06-10 2019-06-07 4 Duncan Barbara Gayle OVID Stock Option (Right to Buy) A - Award D 1,60 5.813 5.813
2019-06-10 2019-06-07 4 WILLIAMS DOUGLAS E OVID Stock Option (Right to Buy) A - Award D 1,60 5.813 5.813
2019-04-08 2019-04-03 4 Perone Thomas Michael OVID Employee Stock Option (Right to Buy) A - Award D 1,92 125.000 125.000
2019-04-03 2019-04-01 4 Rakhit Amit OVID Employee Stock Option (Right to Buy) A - Award D 1,76 50.000 50.000
2019-04-03 2019-04-01 4 During Matthew OVID Stock Option (Right to Buy) A - Award D 1,76 75.000 75.000
2019-02-28 2019-02-26 4 Bernstein Karen OVID Common Stock P - Purchase D 2,0210 10.000 20 20.000
2019-02-26 2019-02-24 4 During Matthew OVID Employee Stock Option (Right to Buy) A - Award D 1,89 70.000 70.000
2019-02-26 2019-02-24 4 LEVIN JEREMY M OVID Employee Stock Option (Right to Buy) A - Award D 1,89 250.000 250.000
2019-02-26 2019-02-22 4 LEVIN JEREMY M OVID Common Stock P - Purchase D 2,0000 75.000 150 4.676.529
2019-02-26 2019-02-24 4 Haasner Dirk OVID Employee Stock Option (Right to Buy) A - Award D 1,89 75.000 75.000
2019-02-26 2019-02-24 4 Ward Ana OVID Employee Stock Option (Right to Buy) A - Award D 1,89 40.000 40.000
2019-02-26 2019-02-24 4 Daly Timothy OVID Employee Stock Option (Right to Buy) A - Award D 1,89 50.000 50.000
2019-02-26 2019-02-24 4 Rakhit Amit OVID Employee Stock Option (Right to Buy) A - Award D 1,89 125.000 125.000
2018-08-29 2018-08-27 4 Rakhit Amit OVID Employee Stock Option (right to buy) A - Award D 6,40 70.000 70.000
2018-08-29 2018-08-27 4 Daly Timothy OVID Employee Stock Option (right to buy) A - Award D 6,40 11.250 11.250
2018-08-29 2018-08-27 4 Ward Ana OVID Employee Stock Option (right to buy) A - Award D 6,40 11.250 11.250
2018-08-29 2018-08-27 4 Haasner Dirk OVID Employee Stock Option (right to buy) A - Award D 6,40 22.500 22.500
2018-08-16 2018-08-14 4 WILLIAMS DOUGLAS E OVID Common Stock P - Purchase D 6,4883 5.000 32 5.000
2018-08-16 2018-08-14 4 Bernstein Karen OVID Common Stock P - Purchase D 6,2300 10.000 62 10.000
2018-06-08 2018-06-07 4 Duncan Barbara Gayle OVID Stock Option (Right to Buy) A - Award D 8,12 5.813 5.813
2018-06-08 2018-06-07 4 Friedman Bart OVID Stock Option (Right to Buy) A - Award D 8,12 5.813 5.813
2018-06-08 2018-06-07 4 WILLIAMS DOUGLAS E OVID Stock Option (Right to Buy) A - Award D 8,12 5.813 5.813
2018-06-08 2018-06-07 4 Bernstein Karen OVID Stock Option (Right to Buy) A - Award D 8,12 5.813 5.813
2018-01-23 2018-01-19 4 Werber Yaron OVID Employee Stock Option (Right to Buy) A - Award D 9,18 131.000 131.000
2018-01-23 2018-01-19 4 LEVIN JEREMY M OVID Employee Stock Option (Right to Buy) A - Award D 9,18 290.000 290.000
2018-01-23 2018-01-19 4 Rakhit Amit OVID Employee Stock Option (Right to Buy) A - Award D 9,18 95.000 95.000
2018-01-23 2018-01-19 4 Ward Ana OVID Employee Stock Option (Right to Buy) A - Award D 9,18 20.000 20.000
2018-01-23 2018-01-19 4 Daly Timothy OVID Employee Stock Option (Right to Buy) A - Award D 9,18 30.000 30.000
2018-01-23 2018-01-19 4 During Matthew OVID Employee Stock Option (Right to Buy) A - Award D 9,18 110.000 110.000
2018-01-23 2018-01-19 4 Haasner Dirk OVID Employee Stock Option (Right to Buy) A - Award D 9,18 30.000 30.000
2017-09-06 2017-09-05 4 Ward Ana OVID Stock Option Grant (Right to Buy) A - Award D 8,38 95.000 95.000
2017-08-28 2017-08-25 4 LEVIN JEREMY M OVID Common Stock P - Purchase D 7,1500 15.334 110 4.601.529
2017-06-15 2017-06-14 4 Duncan Barbara Gayle OVID Stock Option (Right to Buy) A - Award D 13,91 11.627 11.627
2017-05-10 2017-05-10 4 Werber Yaron OVID Employee Stock Option (Right to Buy) A - Award D 8,50 93.022 93.022
2017-05-10 2017-05-10 4 Daly Timothy OVID Employee Stock Option (Right to Buy) A - Award D 8,50 46.510 46.510
2017-05-10 2017-05-10 4 During Matthew OVID Series A Preferred Stock C - Conversion D -28.245 0
2017-05-10 2017-05-10 4 During Matthew OVID Common Stock C - Conversion D 28.245 4.307.314
2017-05-10 2017-05-10 4 LEVIN JEREMY M OVID Series B Preferred Stock C - Conversion I -35.461 0
2017-05-10 2017-05-10 4 LEVIN JEREMY M OVID Series A Preferred Stock C - Conversion D -400.150 0
2017-05-10 2017-05-10 4 LEVIN JEREMY M OVID Common Stock C - Conversion I 35.461 35.461
2017-05-10 2017-05-10 4 LEVIN JEREMY M OVID Common Stock C - Conversion D 400.150 4.586.195
2017-05-04 3 During Matthew OVID Common Stock D 8.930.230
2017-05-04 3 During Matthew By Somnium Trust Z OVID Common Stock I 4.744.184
2017-05-04 3 During Matthew By Somnium Trust M OVID Common Stock I 4.744.184
2017-05-04 3 During Matthew By Somnium Trust L OVID Common Stock I 4.744.184
2017-05-04 3 During Matthew By Somnium Trust F OVID Common Stock I 4.744.184
2017-05-04 3 During Matthew By Somnium Trust Z OVID Common Stock I 4.744.184
2017-05-04 3 During Matthew By Somnium Trust M OVID Common Stock I 4.744.184
2017-05-04 3 During Matthew By Somnium Trust L OVID Common Stock I 4.744.184
2017-05-04 3 During Matthew By Somnium Trust F OVID Common Stock I 4.744.184
2017-05-04 3 During Matthew OVID Common Stock D 8.930.230
2017-05-04 3 LEVIN JEREMY M OVID Common Stock I 5.116.277
2017-05-04 3 LEVIN JEREMY M OVID Common Stock D 8.837.206
2017-05-04 3 LEVIN JEREMY M OVID Common Stock I 5.116.277
2017-05-04 3 LEVIN JEREMY M OVID Common Stock D 8.837.206
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Other Listings
DE:1OT 2,26 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista